DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Traumatic Brain Injury Pipeline Highlights - 2016 Update" drug pipelines to their offering.
Traumatic Brain Injury Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Traumatic Brain Injury market. It covers emerging therapies for Traumatic Brain Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Traumatic Brain Injury pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Traumatic Brain Injury pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Traumatic Brain Injury pipeline products by the company.
Short-term Launch Highlights:
Find out which Traumatic Brain Injury pipeline products will be launched in the US and Ex-US till 2019.
Key Topics Covered:
1. Traumatic Brain Injury Pipeline by Stages
2. Traumatic Brain Injury Pipeline by Drug Class
3. Traumatic Brain Injury Pipeline by Company
4. Traumatic Brain Injury Phase 3 Clinical Trial Insights
5. Traumatic Brain Injury Phase 2 Clinical Trial Insights
6. Traumatic Brain Injury Phase 1 Clinical Trial Insights
7. Traumatic Brain Injury Preclinical Research Insights
8. Traumatic Brain Injury Discovery Stage Insights
9. Appendix
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/6zc6jg/traumatic_brain
